Newborn screening is recognized as an essential, preventive public health program for early identification of disorders in newborns. Screening programs began with one man, Dr. Robert Guthrie, who in the 1960's developed a screening test for phenylketonuria (PKU), the first disorder for which…

As the biotechnology industry becomes more global, companies must evaluate and adopt various cross-border strategic models to drive capital formation and growth. Reforms within China affecting the biomedical industry, such as the accelerated review and approval of drugs, and the expansion of the…

The next big medical breakthrough is on the horizon and all it takes is one idea, one vision, or one conversation for a small, emerging biotech to change the way we treat and cure diseases for generations to come. Recognizing the potential and promise of early-stage companies for addressing unmet…

The next big medical breakthrough is on the horizon and all it takes is one idea, one vision, or one conversation for a small, emerging biotech to change the way we treat and cure diseases for generations to come. Recognizing the potential and promise of early-stage companies for addressing unmet…

Most new medicines are developed through a process of collaborative licensing agreements or acquisition. Significant negotiations underlie multiple steps of the R&D lifetime for a medicine and potential partners often repeat within a given therapeutic focus or geographic expansion strategy…

Dr. Akshaya Shanmugam has always believed that healthcare should be accessible and affordable to everyone and that technology can help deliver that promise. With her strong background in biomedical engineering, she decided to take on a problem facing over 200 million people in the US: addiction. In…

Australia’s University of Queensland is currently conducting research on how gene editing could tailor sugarcane to efficiently produce bioplastics and biofuels. From soda bottles to ethanol, researchers are testing multiple varieties of sugarcane that could be used in new applications that would…

Fighting for diversity in the workplace is more than a “feel good” or “the right thing to do” proposition. Indeed, an environment of inclusion often broadens the talent pool and perspective of companies which, in turn, can make those companies more successful. Today we celebrate International Women…

Despite considerable pressure directed squarely at biotech innovators from politicians of every stripe, biotech executives remained focused on finding the medicines of tomorrow at the BIO CEO & Investor Conference. New York, host of the event for the past 21 years, continues to be a premier…

In his State of the Union address, President Trump called on Congress to “do more” to lower drug costs in the United States. Already, the U.S. Department of Health and Human Services (HHS) has proposed piloting an International Pricing Index payment model, tying costs for drugs under Medicare Part…